The stronger statistically significant anti-proliferative individual effect of PAX treatment was observed in MCF7 luminal BC cells (PAX2.0 = 9.665%) than in MDA-MB-231 TNBC cells (Fig. 5) (PAX2.0 = 50.88%) (with Student’s t test: t = 7.138, df = 6, p = 0.0004). This evidence concerns the gene PAX2 and breast cancer.